Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed with results

Key Signals

3 with results67% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (9)
P 1 (1)
P 2 (1)
P 3 (1)

Trial Status

Completed4
Recruiting3
Enrolling By Invitation3
Terminated2
Active Not Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (13)

Research Network

Activity Timeline